Clinical Trial

Impact of Filtration on Autologous Serum Eye Drops

Study acronym: IFILCOSA
Completed
View on ClinicalTrials.gov →
Summary
Dry eye disease accounts for nearly 25% of ophthalmology consultations, making it a commonly encountered condition. When conventional treatments fail autologous serum in the form of eye drops, have been proposed as a therapeutic option. With the aim of standardizing the preparation of autologous serum eye drops in France, the main objective is to describe the absolute and relative differences (before and after filtration) in the concentrations of active molecules in the autologous serum of patients suffering from severe dry eye disease.
Protocol Amendment History 4 changes
critical Trial completed 2026-05-30
notable Primary completion moved earlier: 2027-04-12 -> 2026-05-18 2026-05-30
minor Completion moved earlier: 2027-04-12 -> 2026-05-18 2026-05-30
critical Recruitment opened 2026-05-13
Trial Details
NCT Number NCT07407101
Lead Sponsor University Hospital, Limoges
Conditions Dry Eye Syndrome (DES)
Enrollment 10 participants
Start Date 2026-04-13
Primary Completion 2026-05-18 (estimated)
Study Completion 2026-05-18 (estimated)
Updated on ClinicalTrials.gov 2026-05-29